AUCTA PHARMACEUTICALS Trademark

Trademark Overview


On Monday, February 21, 2022, a trademark application was filed for AUCTA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the AUCTA PHARMACEUTICALS trademark a serial number of 97276478. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, June 4, 2024. This trademark is owned by Aucta Pharmaceuticals, Inc.. The AUCTA PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of seizures, bipolar disorders, depression and neurofibromatosis; Pharmaceutical preparations for the prevention and treatment of central nervous system disorders, neurological diseases and disorders, neurodegenerative disorders, and depression; pharmaceutical preparations for the treatment of seizures in epilepsy, mood changes in bipolar disorders and depression and lesion reduction in neurofibromatosis and agents in the nature of drug delivery agents in the form of liquids, extended-release oral solids, inhalation and topical formulations that facilitate the delivery of pharmaceutical preparations
aucta pharmaceuticals

General Information


Serial Number97276478
Word MarkAUCTA PHARMACEUTICALS
Filing DateMonday, February 21, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of seizures, bipolar disorders, depression and neurofibromatosis; Pharmaceutical preparations for the prevention and treatment of central nervous system disorders, neurological diseases and disorders, neurodegenerative disorders, and depression; pharmaceutical preparations for the treatment of seizures in epilepsy, mood changes in bipolar disorders and depression and lesion reduction in neurofibromatosis and agents in the nature of drug delivery agents in the form of liquids, extended-release oral solids, inhalation and topical formulations that facilitate the delivery of pharmaceutical preparations
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAucta Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854

Party NameAucta Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854

Trademark Events


Event DateEvent Description
Thursday, February 24, 2022NEW APPLICATION ENTERED
Thursday, February 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 21, 2022ASSIGNED TO EXAMINER
Monday, March 21, 2022NON-FINAL ACTION WRITTEN
Monday, March 21, 2022NON-FINAL ACTION E-MAILED
Monday, March 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 27, 2023SOU EXTENSION 1 FILED
Tuesday, June 27, 2023SOU EXTENSION 1 GRANTED
Thursday, June 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 27, 2023SOU EXTENSION 2 FILED
Wednesday, December 27, 2023SOU EXTENSION 2 GRANTED
Friday, December 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 4, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 4, 2024SOU EXTENSION 3 FILED
Tuesday, June 4, 2024SOU EXTENSION 3 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED